Herzan Introduces The NanoVault
Next generation acoustic enclosure promises quiet environment for high precision research.
Jan 24th, 2008
Read more
Subscribe to our Nanotechnology Business News feed
Metryx Receives Multiple System Follow-On Order from Inotera
Mass metrology innovators, Metryx, Limited, today announced the receipt of a multiple system follow-on order from Taiwanese semiconductor memory manufacturer, Inotera Memories, Inc. The order is for Metryx's Mentor DF3 platform and will be used initially to monitor etch applications.
Jan 24th, 2008
Read moreTegal Ships Plasma Etch System to Top-Ten European Semiconductor Manufacturer or Automotive MEMS
Mid-range autos expected to go from 40 to 60 MEMS devices per vehicle by 2011.
Jan 24th, 2008
Read moreBioForce Nanosciences Reorganizes Management Team to Reflect Transition to Commercial Enterprise
BioForce Nanosciences Holdings, Inc., a producer of integrated biological and mechanical systems for life science researchers at the micro and nano scales, today announced that Kerry Frey, formerly President and Chief Operating Officer, will now be President and Chief Executive Officer. Eric Henderson, who was Chief Executive Officer, will now be Executive Vice President and Chief Science Officer, a newly created position.
Jan 24th, 2008
Read moreNano Chemical Systems Inc. Announces Letter of Intent to Acquire Calgenex Corporation
Nano Chemical Systems Holdings, Inc. announced today that it has entered into a Letter of Intent with Calgenex Corporation for the acquisition of Calgenex by Nanochem.
Jan 24th, 2008
Read moremPhase/AlwaysReady Announce Strategic Direction for 2008
mPhase/AlwaysReady, Inc., a micro and nanotechnology development company focused on advanced power and sensing solutions, today announced the completion of its 2008 strategic planning process, resulting in several new corporate developments that will accelerate the commercialization path of its revolutionary nanotechnology-based battery.
Jan 24th, 2008
Read moreNew Direction For Printed Electronics In 2008
The money spent on printed and potentially printed electronics doubled in 2007, as did the number of organisations participating. There are now about 1500 organisations doing significant work, most of them being academic. In 2008, there will be much more emphasis on commercialisation and many more countries will join the fray.
Jan 24th, 2008
Read moreMoscow State University Buys Russia's First IBM Blue Gene Supercomputer
Moscow State University and IBM announced details of an agreement to install a Blue Gene/P supercomputer at the Department of Computational Mathematics and Cybernetics. The new supercomputer, the first installation of the world famous Blue Gene computer in Russia, will be used for fundamental research in nanotechnology, new materials and life sciences.
Jan 24th, 2008
Read morepSivida Announces pSiNutria Business sold to Intrinsiq Materials
pSivida Limited, a global drug delivery company, and Intrinsiq Materials Cayman Limited today announced that the assets of pSiNutria Limited, a wholly owned subsidiary of pSivida, has been sold to Intrinsiq Materials, a UK based venture capital backed company.
Jan 23rd, 2008
Read moreIntroduction to Low Pressure Gas Dynamic Spray Physics Technology Is Available Now
Written by the inventor of the Gas Dynamic Spray (GDS) technique, this first monograph on the topic brings the understanding of the GDS coating formation process to a new qualitative nanostructural level, while introducing it to industrial and technological experts so that they can develop a new generation of coatings materials.
Jan 23rd, 2008
Read moreNanochip Raises $14 Million to Complete Development of Ultra-High-Capacity Removable Data Storage Chips
Series C2 funding to support prototype development, design verification and sampling of removable chips for computer, server and consumer electronics markets.
Jan 23rd, 2008
Read moreIndustrial Nanotech, Inc. Experiences Rapid Expansion of Global Distribution Network
Industrial Nanotech, Inc. announced that the Company's patented Nansulate energy saving protective coatings are now sold in 33 countries and applicants for Exclusive Distributor status are currently under review for the countries of Russia, India, Sweden, Brunei, Bulgaria, Romania, and Korea. Negotiations for placement of the Company's products in retail stores are underway in the US, New Zealand, Canada, and Europe.
Jan 23rd, 2008
Read moreNanometrics to Announce Fourth Quarter 2007 Financial Results on February 20, 2008
Nanometrics Incorporated, a leading supplier of advanced metrology equipment to the semiconductor industry, will release its fourth quarter and fiscal year 2007 financial results after market close on February 20, 2008. A conference call to discuss the results will be held at 5 PM ET.
Jan 23rd, 2008
Read moreOnexim Group Revealed Its First Project In The Area Of Nanotechnology
Yesterday, Onexim Group revealed its first project in the area of nanotechnology. It proposes to build a research and technology center in Moscow, which may cost more than USD 100 million to implement considering the required equipment, RBC Daily wrote today.
Jan 23rd, 2008
Read moreZecotek Announces High-Power, High-Resolution Laser Spectrometer
Zecotek Photonics Inc. officially announced the launch of its new computerized, high-power, high-resolution laser spectrometer. The device was specifically developed to meet a rapidly growing demand for higher precision spectrometry in nano- and bio-technological applications. Zecotek's latest offering pushes the limits of the precise spectral measurements and technological procedures required in these fields.
Jan 23rd, 2008
Read moreAbraxis Receives Approval to Market ABRAXANE for Metastatic Breast Cancer in Europe
Abraxis BioScience, Inc., an integrated biotechnology company, today announced that the European Commission has granted marketing approval for ABRAXANE powder for suspension for infusion (an albumin-bound nanoparticle formulation of paclitaxel) for the treatment of metastatic breast cancer in patients who have failed first-line treatment for metastatic disease and for whom standard, anthracycline-containing therapy is not indicated.
Jan 23rd, 2008
Read more